Eli Lilly Beats Estimates With New Product Optimism

3 months ago

Critty Gupta

"Nathan, I'm going to end with some positivity if I can here. Eli Liy shares, they're higher. They're excited about their new products. higher by 5 1.5% LLY, boosting their revenue forecast and beating their estimate."

The commentary shifts to a positive note for Eli Lilly (LLY), where strong revenue forecast revisions and beating estimates, driven by new products, are lifting the share price slightly.

Related Stocks